Cellular Dynamics International Inc (ICEL) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
525 SCIENCE DRIVE MADISON, WI 53711 |
| State of Incorp. | WI |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2836 - Biological Products, Except Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2014 | 12/31/2013 | |||
|---|---|---|---|---|
| ASSETS | ||||
| Current Assets | ||||
| Cash, cash equivalents, and short-term investments | 62,029 | |||
| Cash and cash equivalents | 62,029 | |||
| Receivables | 3,318 | |||
| Inventory, net of allowances, customer advances and progress billings | 3,884 | |||
| Inventory | 3,884 | |||
| Other undisclosed current assets | 964 | |||
| Total current assets: | 70,195 | |||
| Noncurrent Assets | ||||
| Property, plant and equipment | 2,052 | |||
| Intangible assets, net (including goodwill) | 10,939 | |||
| Goodwill | 6,817 | |||
| Intangible assets, net (excluding goodwill) | 4,122 | |||
| Regulated entity, other noncurrent assets | 199 | |||
| Other noncurrent assets | 10 | |||
| Total noncurrent assets: | 13,200 | |||
| TOTAL ASSETS: | 83,395 | |||
| LIABILITIES AND EQUITY | ||||
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 6,196 | |||
| Employee-related liabilities | 1,024 | |||
| Accounts payable | 1,811 | |||
| Accrued liabilities | 3,361 | |||
| Debt | 18 | |||
| Deferred revenue and credits | 1,439 | |||
| Other undisclosed current liabilities | (1,024) | |||
| Total current liabilities: | 6,629 | |||
| Noncurrent Liabilities | ||||
| Long-term debt and lease obligation | 11,879 | |||
| Long-term debt, excluding current maturities | 11,879 | |||
| Total noncurrent liabilities: | 11,879 | |||
| Total liabilities: | 18,508 | |||
| Equity | ||||
| Equity, attributable to parent | 64,887 | |||
| Common stock | 2 | |||
| Additional paid in capital | 171,907 | |||
| Accumulated deficit | (107,022) | |||
| Total equity: | 64,887 | |||
| TOTAL LIABILITIES AND EQUITY: | 83,395 | |||
Income Statement (P&L) ($ in thousands)
| 12/31/2014 | 12/31/2013 | ||
|---|---|---|---|
| Revenues (Revenue, Net) | 11,884 | ||
| Cost of revenue (Cost of Goods and Services Sold) | (2,302) | ||
| Gross profit: | 9,582 | ||
| Operating expenses | (36,147) | ||
| Operating loss: | (26,565) | ||
| Nonoperating expense (Other Nonoperating expense) | (695) | ||
| Interest and debt expense | (716) | ||
| Loss from continuing operations: | (27,976) | ||
| Loss before gain (loss) on sale of properties: | (27,976) | ||
| Net loss: | (27,976) | ||
| Other undisclosed net income attributable to parent | 3,018 | ||
| Net loss available to common stockholders, diluted: | (24,958) | ||
Comprehensive Income ($ in thousands)
| 12/31/2014 | 12/31/2013 | ||
|---|---|---|---|
| Net loss: | (27,976) | ||
| Comprehensive loss, net of tax, attributable to parent: | (27,976) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.